BiogenIdec

FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tue, 07/22/14 - 05:08 pm
BiogenIdec
Tecfidera
MS
multiple sclerosis
patents
Actavis
Mylan
Synthon Pharmaceuticals
Novartis
Hexal
Sanofi
Zentiva
What to Watch for in Biotech Earnings This Week
Motley Fool
Tue, 04/22/14 - 09:33 am
biotech
earnings
Gilead Sciences
Celgene
Amgen
BiogenIdec
Between RX and A Hard Place: Biotechs Flash Warnings
Investors.com
Tue, 08/13/13 - 11:00 am
Alexion
BiogenIdec
Santarus
Regeneron
Biogen Gains A Leg Up In Fiercely Competitive MS Field
Seeking Alpha
Thu, 08/8/13 - 06:54 pm
BiogenIdec
MS
multiple sclerosis
Tecfidera
Biotech Stocks Under Pressures, Focus On IPOs
Property Mentor Group
Fri, 07/26/13 - 11:37 am
IPOs
Sequenom
Invovio
Aeterna Zentaris
Sarepta
InterMune
Cryolife
BiogenIdec
Boston Scientific
Varian Medical
Warner Chilcott
GlaxoSmithKline, Biogen Idec strike antibody deals with biotech startup Adimab
Fierce Biotech
Fri, 07/26/13 - 11:33 am
Adimab
GSK
BiogenIdec
antibody discovery
A Look at Four Major Players in Multiple Sclerosis Treatments
Motley Fool
Wed, 07/24/13 - 12:55 pm
MS
multiple sclerosis
XenoPort
BiogenIdec
Novartis
Alkermes
Tecfidera
Gilenya
ALKS 7106
Biogen Idec Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Wed, 07/24/13 - 09:45 am
BiogenIdec
earnings
Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline
TheStreet.com
Thu, 07/18/13 - 09:55 am
Alkermes
multiple sclerosis
MS
monomethyl fumarate
Tecfidera
BiogenIdec
3 Bio Companies Facing The Patent Cliff
Seeking Alpha
Tue, 05/7/13 - 05:31 pm
patents
patent cliff
AbbVie
BiogenIdec
Eisai
JNJ
Eli Lilly
Novartis
Sanofi
Roche
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Alexza
BiogenIdec
Celsion
Celgene
Sanofi
JNJ
Threshold Pharmaceuticals
Biogen's New Hemophilia Drug Could Replace Pfizer's Old One
Forbes
Wed, 09/26/12 - 11:00 am
hemophilia
Pfizer
BiogenIdec
factor IX
BeneFix
Battle Lines Drawn in the MS Market
Motley Fool
Wed, 09/26/12 - 10:56 am
multiple sclerosis
MS
BiogenIdec
BG-12
Sanofi
Aubagio
Gilenya
Novartis
Multiple sclerosis drugs seen gaining traction
Marketwatch
Fri, 09/21/12 - 11:32 am
MS
multiple sclerosis
BiogenIdec
BG-12
Aubagio
Sanofi
Is Biogen Too Good To Be True?
Seeking Alpha
Tue, 09/18/12 - 04:44 pm
BiogenIdec
Avonex
Tysabri
Fampyra
Fumaderm
Biogen, Shire, Novo top pharma ranking of shareholder value
Fierce Pharma
Tue, 09/18/12 - 12:54 pm
BiogenIdec
Shire
Novo Nordisk
Rituxan And Its Biosimilar Competitors
Seeking Alpha
Mon, 07/30/12 - 10:28 am
Rituxan
BiogenIdec
Halozyme
Hospira
iBio
Lonza
Merck
Novartis
Pfizer
Roche
Spectrum Pharmaceuticals
cancer
Viropro
Teva Pharmaceuticals
Biogen Second-Quarter Profit Rises As Avonex Sales Increase
Bloomberg
Tue, 07/24/12 - 11:11 am
earnings
BiogenIdec
Earnings Preview: Biogen
Yahoo/Zacks
Mon, 07/23/12 - 10:34 pm
BiogenIdec
earnings

Pages